You are here: Industry Insights > Abbott

News List

Abbott launches new initiative to drive diversity in medical research and improve care among under-represented populations WorldPharmaNews
November 04, 2021
Abbott (NYSE: ABT) today announced the launch of a new initiative designed to help create a more inclusive clinical trial ecosystem through new approaches to training, education, and improving the clinical research
Mentice receives order of total SEK 7.0 million from ABBOTT prnasia
October 18, 2021
Mentice AB (publ) a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, has through its fully owned subsidiary Mentice Inc entered into an agreement with ABBOTT Inc.
Abbott launches Panbio COVID-19 Antigen Self-Test in India expresspharma
July 14, 2021
The self-test features a minimally invasive nasal swab and delivers results in as early as15 minutes with no instrumentation.
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care expresspharma
June 01, 2021
The company has entered into an agreement with Abbott Point of Care (APOC), the medical and diagnostics devices division of Abbott, for the distribution, marketing and promotion of the entire range of products by APOC in the entire country of India.
Abbott’s AI-powered coronary imaging platform deployed in the UK pharmatimes
May 14, 2021
Abbott UK’s artificial intelligence- (AI) powered coronary imaging platform has been offered to the first heart attack patients in the country at the Royal Free Hospital in London.
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge prnasia
April 20, 2021
Efforts to ramp up COVID-19 testing capacity in the Philippines have received fresh impetus, with the Office of the Civil Defense (OCD) procuring and distributing the Abbott Panbio™ COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 ...
Abbott forms Pandemic Defense Coalition expresspharma
March 15, 2021
Abbott announced the formation of the Abbott Pandemic Defense Coalition, a global scientific and public health partnership for early detection of, and rapid response to, future pandemic threats.
Abbott introduces NeuroSphere™ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S. worldpharmanews
March 12, 2021
Abbott announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed.
Abbott Receives EUA for PCR Assay That Detects, Differentiates SARS-CoV-2, Flu, RSV in One Test americanpharmaceuticalreview
March 11, 2021
Abbott announced U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the company's Alinity™ m Resp-4-Plex molecular assay to detect and differentiate SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) ...
Abbott researchers find rare group of people with controlled HIV who could be a key to unlocking cure worldpharmanews
March 04, 2021
Abbott announced today that a team of scientists has found an unusually high number of people in the Democratic Republic of Congo (DRC) who test positive for HIV antibodies, but have low to non-detectable viral load counts - without the use of ...

Previous page 1 2 3 4 5 6 7 Next page